A Cincinnati-led genetics deep dive released Tuesday is putting kids' DNA in the spotlight, finding that most children with recurrent or chronic pancreatitis carry inherited risk variants, and that some of those variants appear to speed the slide from a first acute attack to long-term disease. Researchers sequenced pancreatitis-related genes in 944 children and flagged about 120 variants that were enriched in patients, including roughly 79 that had not previously been tied to pancreatitis. The results give clinicians more support for broader genetic testing and earlier referrals to specialized pediatric pancreatitis programs.
According to Cincinnati Children’s Research Horizons, the paper, co-first-authored by Wenying Zhang and Maisam Abu-El-Haija, pulls from the INSPPIRE registry and the NIH-funded consortium that supports it. The team sequenced genes long associated with pediatric pancreatitis, including PRSS1, CFTR, SPINK1, CTRC, CASR, and CPA1, then narrowed the data set for more focused analysis.
Key findings from the genetic analysis
As published in Clinical Gastroenterology and Hepatology, 74% of the 944 children carried at least one focused genetic risk variant, and children with any such variant moved more quickly from a first acute pancreatitis episode to chronic pancreatitis than those without. The team identified 120 variants that were more common in pediatric patients than in the general population and singled out 79 variants that had not previously been associated with pancreatitis. Researchers then focused a detailed analysis on 38 variants across nine genes. Variants in PRSS1, CTRC, and SPINK1 were linked to faster progression, while CASR and CPA1 variants were more common in acute recurrent pancreatitis and were associated with slower progression to chronic disease.
What it means for families and clinicians
For families, the study underlines that recurrent and chronic pancreatitis in children often has a genetic component and may not be truly idiopathic, the authors note. "Knowing a child’s genetic profile may help families and clinicians make more informed decisions earlier in the course of disease," Maisam Abu-El-Haija said in Cincinnati Children’s Research Horizons, adding that genetic results should always be read alongside clinical history, imaging findings, and symptoms.
Why the consortium approach matters
The analysis was carried out on behalf of the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) and involved 34 co-authors from more than 20 institutions, which gives the results cross-center weight. According to CPDPC, the work was supported by National Institutes of Health grants, and the authors say the next steps include functional studies to test how the newly identified variants change pancreatic biology and whether genetic profiles can help guide surveillance or more targeted care.
A note of caution
Experts stress that carrying a risk variant is not a guarantee of disease, since genetics is only one part of a multifactorial picture that also includes anatomy, environment, and the frequency of acute episodes. Clinical reviews and guidance recommend interpreting genetic results in the context of symptoms and imaging, but researchers say the scale of this study gives clinicians and families stronger data when weighing testing and follow-up. For background on genetic testing and pancreatitis, see GeneReviews.
